Primary amelanotic leptomeningeal melanocytosis mimicking subarachnoid hemorrhage: a case report of the deceptive masquerader
-
By
-
Yu-Chung Juan
-
John S. Kuo
-
Chun-Chung Chen
-
Ren-Ching Wang
-
Der-Yang Cho
-
Yu-Kai Cheng
-
April 30, 2026
-
Clinical Scorecard: Amelanotic Primary Diffuse Leptomeningeal Melanocytosis Presenting as Subarachnoid Hemorrhage: A Case Study of a Clinical Mimicker
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Young adults, particularly those without neurocutaneous stigmata, aged 18-35. |
| Care Setting | |
Key Highlights
- Add: CSF analysis is crucial for ruling out other conditions.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Regular neurological assessments and imaging (MRI/CT) to monitor disease progression.
Risks
Patient & Prescribing Data
Targeted therapy (e.g., MEK inhibitors) may be beneficial but requires timely diagnosis.
Clinical Best Practices
- Emphasize interdisciplinary consultation for complex diagnostic cases.
References
